Smith v. Pingree

651 F.2d 1021, 1981 U.S. App. LEXIS 11050
CourtCourt of Appeals for the Fifth Circuit
DecidedJuly 27, 1981
Docket80-5309
StatusPublished
Cited by3 cases

This text of 651 F.2d 1021 (Smith v. Pingree) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Smith v. Pingree, 651 F.2d 1021, 1981 U.S. App. LEXIS 11050 (5th Cir. 1981).

Opinion

651 F.2d 1021

Tom SMITH, Herbert Gorlin, Individually and on behalf of
others similarly situated and The Florida Hearing
Aid Society, Inc., Plaintiffs-Appellants,
v.
David H. PINGREE, in His Official Capacity as Secretary of
the Florida Department of Health and
Rehabilitative Services, Defendant-Appellee.

No. 80-5309.

United States Court of Appeals,
Fifth Circuit.

Unit B

July 27, 1981.

Jon D. Caminez, Tallahassee, Fla., for plaintiffs-appellants.

Chester G. Senf, Charles T. Collette, Fla. Dept. of Health & Rehab. Serv., Tallahassee, Fla., for defendant-appellee.

Appeal from the United States District Court for the Northern District of Florida.

Before GEWIN*, RONEY and HATCHETT, Circuit Judges.

HATCHETT, Circuit Judge:

Appellants, hearing aid dispensers licensed in Florida, appeal a decision upholding the validity of three sections of Florida's Fitting and Selling of Hearing Aids Act, Florida Statute § 468.120 et seq. Appellants contend that the Testing Room Requirement, § 468.135(7), the Receipt Requirement, § 468.136(1), and the Labeling Requirement, § 468.136(2), are preempted by federal law in 21 U.S.C. § 360k and by regulations promulgated by the Food and Drug Administration in 21 C.F.R. §§ 801.420 and 801.421. Because we find that none of the challenged state requirements has been preempted by federal regulation, we affirm the decision of the district court granting appellant's motion for summary judgment.

In 1978, the Florida Legislature amended the Fitting and Selling of Hearing Aids Act, Florida Statute § 468.120 et seq., by adding § 468.135, which prescribes the minimum procedures and equipment to be used in the fitting and selling of hearing aids. The legislature also added section 468.136, which requires a hearing aid dispenser to give a purchaser a receipt containing certain required information, and which also covers labeling requirements for the hearing aid package. Appellants brought this action in the district court in 1978 seeking declaratory and injunctive relief against the enforcement of these Florida statutes, claiming they are preempted by the federal regulatory scheme for the manufacture and sale of hearing aids embodied in the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 et seq., and the regulations promulgated thereunder. The district court entered summary judgment for the state, and this appeal followed.

We must determine whether section 468.135(7) and sections 468.136(1) and (2) of the Florida statutes have been preempted by federal regulations in 21 C.F.R. §§ 801.420 and 801.421.

THE TEST OF PREEMPTION

In order to resolve this issue, we must consider Congress's command as to the preemptive effect of its regulatory scheme in the field. The operative federal statute is 21 U.S.C. § 360k, which reads in part:

(a) (N)o state ... may establish ... with respect to a device intended for human use any requirement

(1) which is different from, or in addition to, any requirement applicable under this statute to the device, and

(2) which relates to the safety or effectiveness of the device or to any other matter included in a requirement applicable to the device under this chapter.

We thus have a two-pronged test to apply to the Florida statutes in question in order to determine whether they are preempted by federal regulation. We must first determine whether the Florida requirements relate to a matter included in the federal regulations, and if so whether Florida's requirements are "different from, or in addition to" any requirement found in the federal regulations.

THE SOUND ROOM REQUIREMENT

We will now compare the Food and Drug Administration regulations with the contested Florida statutes in light of the preemption test of 21 U.S.C. § 360k. The Food and Drug Administration regulations governing hearing aids include 21 C.F.R. § 801.421, which reads in part:

Hearing aid devices; conditions for sale.

(a) Medical evaluation requirements (1) General. Except as provided in paragraph (a)(2) of this section, a hearing aid dispenser shall not sell a hearing aid unless the prospective user has presented to the hearing aid dispenser a written statement signed by a licensed physician that states that the patient's hearing loss has been medically evaluated and the patient may be considered a candidate for a hearing aid. The medical evaluation must have taken place within the preceding 6 months.

(2) Waiver to the medical evaluation requirements. If the prospective hearing aid user is 18 years of age or older, the hearing aid dispenser may afford the prospective user an opportunity to waive the medical evaluation requirement of paragraph (a)(1) of this section provided that the following hearing aid dispenser: (here follows certain requirements).

Appellants contend that the conditions for sale in the above regulation preempt Florida's requirements setting forth the minimal procedure and equipment to be used in the fitting and selling of hearing aids in Florida Statute § 468.135. Subsection (7) of that statute, which is the only portion challenged by the appellants, reads in part:

Each audiometric test conducted by a registrant in the fitting and selling of hearing aids shall be made in a testing room that has been certified by the department not to exceed the sound-pressure levels at frequencies specified by the department. The exception to this requirement shall be in the case of a client who requests that the test be conducted in a place other than the registrant's certified testing room. When a test is conducted under this exception, the registrant shall obtain a waiver from the client on a form provided by the department. The executed waiver shall be attached to the client's copy of the contract, and a copy of the executed waiver shall be retained in the registrant's file.

Part 801 of the Food and Drug Administration regulations, 21 C.F.R. § 801, deals primarily with labeling provisions. The section dealing with conditions for sale of hearing aids is 21 C.F.R. § 801.421. The first part of that section, quoted above, sets out the requirements for a medical evaluation prior to sale of a hearing aid. The second and third parts of that section require a dispenser to provide a purchaser or prospective purchaser with a copy of the User Instructional Brochure. The fourth part of the section requires a dispenser to retain for three years a copy of any written statement from a physician or any written statement waiving medical evaluation. Read as a whole, then, the purpose of § 801.421 is to insure that the prospective purchaser of a hearing aid is provided with sufficient information to make an intelligent decision as to whether to purchase a hearing aid. This section thus addresses the conditions for sale of hearing aid devices, rather than the mechanics of properly fitting the device to the patient.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Lohr v. Medtronic, Inc.
Eleventh Circuit, 1995
Mitchell v. Iolab Corp.
700 F. Supp. 877 (E.D. Louisiana, 1988)
Ago
Florida Attorney General Reports, 1985

Cite This Page — Counsel Stack

Bluebook (online)
651 F.2d 1021, 1981 U.S. App. LEXIS 11050, Counsel Stack Legal Research, https://law.counselstack.com/opinion/smith-v-pingree-ca5-1981.